10th Servier-IGIS symposium

Proceedings of the Tenth Servier-IGIS Symposium.

This Symposium and the publication of the present supplement have been made possible by an unrestricted educational grant from Servier, Paris.

Diabetes, Obesity and Metabolism

Volume 11, Supplement 4, November 2009

Editorial

Beta-Cell research – A decade of rapid growth.
Ahrén B, Accili D, Boitard C, Efendic S, Henquin JC, Seino S, Steiner DF, Cerasi E.
Diabetes Obes Metab. 2009 Nov;11 Suppl 4:iv-ix. No abstract available.

Original Articles

Balancing needs and means: the dilemma of the beta-cell in the modern world.
Leibowitz G, Kaiser N, Cerasi E.
Diabetes Obes Metab. 2009 Nov;11 Suppl 4:1-9.

Lipid receptors and islet function: therapeutic implications?
Kebede MA, Alquier T, Latour MG, Poitout V.
Diabetes Obes Metab. 2009 Nov;11 Suppl 4:10-20.

The roles of telomeres and telomerase in beta-cell regeneration.
Liew CW, Holman A, Kulkarni RN.
Diabetes Obes Metab. 2009 Nov;11 Suppl 4:21-9.

Pdx1 and other factors that regulate pancreatic beta-cell survival.
Fujimoto K, Polonsky KS.
Diabetes Obes Metab. 2009 Nov;11 Suppl 4:30-7.

Genetic and biochemical pathways of beta-cell failure in type 2 diabetes.
Talchai C, Lin HV, Kitamura T, Accili D.
Diabetes Obes Metab. 2009 Nov;11 Suppl 4:38-45.

Adult human beta-cell neogenesis?
Demeterco C, Hao E, Lee SH, Itkin-Ansari P, Levine F.
Diabetes Obes Metab. 2009 Nov;11 Suppl 4:46-53.

Beta-Cells at the crossroads: choosing between insulin granule production and proliferation.
Liu Y, Mziaut H, Ivanova A, Solimena M.
Diabetes Obes Metab. 2009 Nov;11 Suppl 4:54-64.

Glucose regulation of islet stress responses and beta-cell failure in type 2 diabetes.
Jonas JC, Bensellam M, Duprez J, Elouil H, Guiot Y, Pascal SM.
Diabetes Obes Metab. 2009 Nov;11 Suppl 4:65-81.

Towards better understanding of the contributions of overwork and glucotoxicity to the beta-cell inadequacy of type 2 diabetes.
Weir GC, Marselli L, Marchetti P, Katsuta H, Jung MH, Bonner-Weir S.
Diabetes Obes Metab. 2009 Nov;11 Suppl 4:82-90.

Transgenic and other experimental models of pancreas and islet damage.
Herrera PL.
Diabetes Obes Metab. 2009 Nov;11 Suppl 4:91-6.

Islet protein profiling.
Bergsten P.
Diabetes Obes Metab. 2009 Nov;11 Suppl 4:97-117.

Role and therapeutic potential of microRNAs in diabetes.
Kolfschoten IG, Roggli E, Nesca V, Regazzi R.
Diabetes Obes Metab. 2009 Nov;11 Suppl 4:118-29.

Bariatric surgery: unstressing or boosting the beta-cell?
Mingrone G, Castagneto M.
Diabetes Obes Metab. 2009 Nov;11 Suppl 4:130-42.

Beneficial effects of K-ATP channel openers in diabetes: an update on mechanisms and clinical experiences.
Grill V, Radtke M, Qvigstad E, Kollind M, Björklund A.
Diabetes Obes Metab. 2009 Nov;11 Suppl 4:143-8.

Genetic basis of beta-cell dysfunction in man.
Groop L, Lyssenko V.
Diabetes Obes Metab. 2009 Nov;11 Suppl 4:149-58.

Cell-cell interactions in the endocrine pancreas.
Jain R, Lammert E.
Diabetes Obes Metab. 2009 Nov;11 Suppl 4:159-67.

Shortcomings of current models of glucose-induced insulin secretion.
Henquin JC, Nenquin M, Ravier MA, Szollosi A.
Diabetes Obes Metab. 2009 Nov;11 Suppl 4:168-79.

Roles of cAMP signalling in insulin granule exocytosis.
Seino S, Takahashi H, Fujimoto W, Shibasaki T.
Diabetes Obes Metab. 2009 Nov;11 Suppl 4:180-8.

A brief perspective on insulin production
Steiner DF, Park SY, Støy J, Philipson LH, Bell GI.
Diabetes Obes Metab. 2009 Nov;11 Suppl 4:189-96.

Inhibitory effect of kisspeptins on insulin secretion from isolated mouse islets.
Vikman J, Ahrén B.
Diabetes Obes Metab. 2009 Nov;11 Suppl 4:197-201.

Zinc, a regulator of islet function and glucose homeostasis.
Wijesekara N, Chimienti F, Wheeler MB.
Diabetes Obes Metab. 2009 Nov;11 Suppl 4:202-14.